Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–15
Headlines
15
Sources here
3
Companies here
3
Current section Brazil Medical Instruments & Supplies news
Latest

finance.yahoo.com Market update

Intuitive Surgical (ISRG) Beats On Q2 As Investors Ask If The Bull Case Is Priced In

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Intuitive Surgical (ISRG) shook investors after reporting strong Q2 2026 revenue and earnings that beat expectations, while revealing slower U.S. procedure growth and rising competitive pressure from Johnson & Johnson and Chinese robotic surgery platforms. See our …

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deterioration. U.S. da Vinci procedures grew 12% in the …

I1SR34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Intuitive Surgical's Competitors Face Challenges That Limit Long-Term Appeal, Oppenheimer Says

Intuitive Surgical's (ISRG) competitors face unique workflow challenges and real estate issues that impact their long-term appeal, while customized price-volume contracts complicate competitors' return on investment and its flexible per-click model allows growth opportunities in Silver Upgrade to read this MT Newswires article and …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

Key Points The robotic surgery specialist has over 12,000 installed systems globally. Right now, it's facing some headwinds, but it also has a lot going for it. The Baron Health Care Fund sees Intuitive Surgical as full of promise.10 stocks we like better than …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

If You Invested $1000 in Intuitive Surgical, Inc. 10 Years Ago, This Is How Much You'd Have Now

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Is Recall-Hit Outlook and Bigger Payout Altering The Investment Case For ResMed (RMD)?

In early August 2026, ResMed reported past fourth-quarter and full-year results showing higher sales and earnings, announced a 10% increase in its quarterly US$0.66 dividend, and confirmed completion of a long-running US$1.40 billions share buyback program. At the same time, management issued a softer …

R1MD34 main company
Sharemaestro market context Price below Trend Line 52 weeks -36.2% · Next-week setup negative 26.8% R1MD34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Align Technology Prevails in China Patent Infringement Action Against Angelalign

SAN JOSE, Calif. & TEMPE, Ariz., August 12, 2026--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a …

A1LG34 main company
Sharemaestro market context Price below Trend Line 52 weeks +15.1% · Next-week setup negative 41.3% A1LG34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Intuitive Surgical (ISRG) Just Beat Earnings. Is the Stock Still Worth Paying a Premium?

Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS of $2.80 exceeding expectations by $0.30. Despite that, the stock plunged due to mounting concerns …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now?

Intuitive Surgical ISRG currently trades at a forward 12-month P/E ratio of 33.02X, above the Medical - Instruments industry's 26.53X, underscoring a valuation premium that investors must weigh against the company's growth prospects. The stock carries a Value Score of D, suggesting that shares …

I1SR34 mentioned
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?

Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J's MedTech ambitions, but the company is entering a market in which …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Resmed’s stock falls by 7% on soft FY27 outlook

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. ResMed stock has lagged over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares …

R1MD34 main company
Sharemaestro market context Price below Trend Line 52 weeks -36.2% · Next-week setup negative 26.8% R1MD34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Intuitive Surgical (ISRG) Stock Looks Fairly Valued Despite Its 33% Slide

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Intuitive Surgical stock has had a difficult start to 2026, with the share price down 32.6% year to date, while the Discounted Cash …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

What Do Intuitive Surgical (ISRG) Bylaw Changes Mean For Shareholders?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Intuitive Surgical (NasdaqGS: ISRG) has approved amendments to its bylaws, updating shareholder voting rules, nomination processes, and procedural requirements in line with recent SEC universal proxy regulations. …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%

Quick Read ISRG dropped 34% on a slower procedure growth guide, yet Q2 EPS of $2.80 crushed the $2.50 consensus for a fifth straight quarterly beat. ISRG trades 28% below Wall Street consensus while peers MDT and SYK fell less than 10% YTD, suggesting …

I1SR34 main company
Sharemaestro market context Price below Trend Line 52 weeks -25.5% I1SR34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context